2m 2m 2m 2m 2m 2m 2m
Teleflex (TFX)
NYSE
$122.89+$1.22 (+1.00%)
Price as of Jun 23, 2026 6:31 PM EDT- $5.4BMarket Cap
- 4.24%1-Year Change
- Medical Instruments & SuppliesIndustry
Teleflex (TFX)
$122.89+$1.22 (+1.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.0B -34.61% | 3.0B +2.45% | 3.0B +6.57% | 2.8B -0.66% | |
Cost of Revenue | 872.0M -35.15% | 1.3B +1.29% | 1.3B +5.37% | 1.3B -0.0006% | |
Gross Profit | 1.1B -34.18% | 1.7B +3.38% | 1.6B +7.57% | 1.5B -1.19% | |
Sales and Marketing Expense | 720.2M -27.64% | 995.3M +7.03% | 929.9M +7.65% | 863.7M +0.43% | |
Research and Development Expense | -144.8M -10.45% | -161.7M +4.74% | -154.4M +0.35% | -153.8M +17.56% | |
Depreciation and Amortization Expense | 121.7M -38.45% | 197.7M +13.62% | 174.0M +6.02% | 164.1M -0.92% | |
Total Operating Expenses | 872.0M -35.15% | 1.3B +1.29% | 1.3B +5.37% | 1.3B -0.0006% | |
Operating Profit | 118.4M -21.61% | 151.0M -70.17% | 506.3M +1.32% | 499.7M -20.44% | |
Interest Income | 6.4M -20.05% | 8.0M -37.34% | 12.8M +1,301.43% | 912,000 -31.33% | |
Interest Expense | N/A N/A | N/A N/A | -85.1M +56.79% | -54.3M -4.75% | |
Interest Income and Expense and Net | 6.4M -20.05% | 8.0M +111.08% | -72.3M +35.52% | -53.4M -4.11% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 85.1M +56.79% | 54.3M -4.75% | |
Income before Taxes | 24.6M -67.47% | 75.5M -82.61% | 434.0M -2.67% | 445.9M -20.30% | |
Income Taxes | -34.0M -739.15% | 5.3M -93.05% | 76.4M -7.91% | 83.0M +11.64% | |
Extraordinary Items | 0 -100.00% | 7.8M N/A | 0 -100.00% | 1.5M -77.79% | |
Net Income | -905.6M -1,399.81% | 69.7M -80.45% | 356.3M -1.88% | 363.1M -25.18% | |
Net Income from Continuing Operations Applicable to Common | 24.6M -67.47% | 75.5M -82.61% | 434.0M -2.67% | 445.9M -20.30% | |
Basic EPS and Net Income | -20.30 -1,462.42% | 1.49 -80.34% | 7.58 -2.07% | 7.74 -25.43% | |
Diluted EPS and Net Income | -20.25 -1,468.24% | 1.48 -80.35% | 7.53 -1.95% | 7.68 -24.93% | |
Basic Weighted Average Shares | 44.6M -4.73% | 46.8M -0.31% | 47.0M +0.18% | 46.9M +0.27% | |
Diluted Weighted Average Shares | 44.7M -5.03% | 47.1M -0.44% | 47.3M -0.01% | 47.3M -0.25% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 378.6M +30.45% | 290.2M +30.22% | 222.8M -23.69% | 292.0M -34.39% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 378.6M +30.45% | 290.2M +30.22% | 222.8M -23.69% | 292.0M -34.39% | |
Total Current Assets | 1.9B +31.76% | 1.5B +4.53% | 1.4B -0.25% | 1.4B -1.27% | |
Accumulated Depreciation | 470.1M -23.03% | 610.7M +6.55% | 573.2M +2.96% | 556.7M -0.23% | |
Property and Plant and Equipment and Net | 498.3M -0.91% | 502.9M +4.78% | 479.9M +7.31% | 447.2M +0.78% | |
Total Long-Term Assets | 113.0M +10.10% | 102.6M +3.72% | 98.9M +10.72% | 89.4M +29.32% | |
Total Assets | 6.9B -2.12% | 7.1B -5.77% | 7.5B +8.73% | 6.9B +0.82% | |
Income Taxes Payable | 202.5M -53.16% | 432.4M -13.09% | 497.5M +20.29% | 413.6M -8.91% | |
Total Short-Term Debt | 100.0M 0.00% | 100.0M +14.29% | 87.5M 0.00% | 87.5M -20.45% | |
Total Current Liabilities | 762.0M +17.35% | 649.4M +7.02% | 606.7M +4.34% | 581.5M -14.50% | |
Total Long-Term Debt | 2.5B +63.35% | 1.6B -9.94% | 1.7B +6.38% | 1.6B -6.67% | |
Total Long-Term Liabilities | 194.5M +90.15% | 102.3M -37.04% | 162.5M +5.48% | 154.1M -1.73% | |
Total Liabilities | 3.8B +35.56% | 2.8B -8.79% | 3.1B +6.38% | 2.9B -6.77% | |
Retained Earnings | 3.1B -23.47% | 4.1B +0.15% | 4.1B +7.66% | 3.8B +8.51% | |
Total Stockholders Equity | 3.1B -26.96% | 4.3B -3.67% | 4.4B +10.42% | 4.0B +7.12% | |
Total Shares Outstanding | 48.2M +0.21% | 48.1M +0.10% | 48.0M +0.19% | 48.0M +0.06% | |
Cash Flow | |||||
Cash from Operating Activities | 340.7M -46.41% | 635.7M +24.50% | 510.6M +49.25% | 342.1M -47.48% | |
Capital Expenditures | 95.2M -24.68% | 126.4M +38.27% | 91.4M +15.47% | 79.2M +10.57% | |
Cash from Investing Activities | -849.2M +754.68% | -99.4M -84.01% | -621.2M +140.84% | -257.9M -264.57% | |
Dividends Paid | 60.3M -5.15% | 63.5M -0.56% | 63.9M +0.17% | 63.8M +0.22% | |
Cash from Financing Activities | 611.5M +244.94% | -421.9M -1,194.77% | 38.5M +117.72% | -217.5M -69.61% | |
Financials Ratio | |||||
Gross Margin | 56.24% +0.66% | 55.87% +0.91% | 55.37% +0.93% | 54.86% -0.54% | |
Operating Margin | 5.94% +19.87% | 4.96% -70.89% | 17.02% -4.93% | 17.90% -19.91% | |
Return on Assets | -12.90% -1,453.92% | 0.95% -80.67% | 4.93% -6.36% | 5.26% -23.97% | |
Return on Equity | -24.47% -1,630.92% | 1.60% -81.02% | 8.42% -9.83% | 9.34% -31.78% | |
Revenue Growth | -34.61% -1,513.31% | 2.45% -62.74% | 6.57% +1,097.07% | -0.66% -106.14% | |
Current Ratio | 2.54 +12.28% | 2.27 -2.33% | 2.32 -4.41% | 2.43 +15.48% | |
Cash Ratio | 0.50 +11.17% | 0.45 +21.67% | 0.37 -26.86% | 0.50 -23.26% | |
Debt-to-Equity Ratio | 0.85 +118.37% | 0.39 -5.29% | 0.41 -3.95% | 0.43 -13.64% | |
Debt-to-Assets Ratio | 0.38 +62.97% | 0.23 -3.20% | 0.24 -2.43% | 0.25 -8.25% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow